Trade-Ideas LLC identified




) as a strong and under the radar candidate. In addition to specific proprietary factors, Trade-Ideas identified Analogic as such a stock due to the following factors:

  • ALOG has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $7.2 million.
  • ALOG has traded 20.5671999999999997044142219237983226776123046875 options contracts today.
  • ALOG is making at least a new 3-day high.
  • ALOG has a PE ratio of 33.
  • ALOG is mentioned 0.42 times per day on StockTwits.
  • ALOG has not yet been mentioned on StockTwits today.
  • ALOG is currently in the upper 20% of its 1-year range.
  • ALOG is in the upper 35% of its 20-day range.
  • ALOG is in the upper 45% of its 5-day range.
  • ALOG is currently trading above yesterday's high.

'Strong and Under the Radar' stocks tend to be worthwhile stocks to watch for a variety of factors including historical back testing and price action. Market technicians refer to such stocks as being in an accumulation phase before a mark-up and peak. Traders and hedge funds have frequently found that these types of stocks continue to build a solid price base and then ultimately spike higher and peak when others 'discover' how good the stock is performing. By leveraging the social discovery aspect of StockTwits we are highlighting stocks that don't currently receive much attention from retail investors, but we suspect may soon garner more attention.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in ALOG with the Ticky from Trade-Ideas. See the FREE profile for ALOG NOW at Trade-Ideas

More details on ALOG:

Analogic Corporation, a technology company, designs, manufactures, and sells medical imaging, ultrasound, and security systems and subsystems to original equipment manufacturers (OEMs) and end users in the healthcare and airport security markets worldwide. The stock currently has a dividend yield of 0.5%. ALOG has a PE ratio of 33. Currently there is 1 analyst that rates Analogic a buy, no analysts rate it a sell, and none rate it a hold.

The average volume for Analogic has been 111,800 shares per day over the past 30 days. Analogic has a market cap of $1.1 billion and is part of the health care sector and health services industry. The stock has a beta of 0.59 and a short float of 9.4% with 12.38 days to cover. Shares are up 4.5% year-to-date as of the close of trading on Wednesday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.


TheStreet Quant Ratings

rates Analogic as a


. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, good cash flow from operations and solid stock price performance. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity.

Highlights from the ratings report include:

  • ALOG's revenue growth trails the industry average of 37.7%. Since the same quarter one year prior, revenues slightly increased by 8.8%. This growth in revenue does not appear to have trickled down to the company's bottom line, displayed by a decline in earnings per share.
  • ALOG has no debt to speak of therefore resulting in a debt-to-equity ratio of zero, which we consider to be a relatively favorable sign. Along with this, the company maintains a quick ratio of 3.18, which clearly demonstrates the ability to cover short-term cash needs.
  • Net operating cash flow has significantly increased by 161.06% to $12.57 million when compared to the same quarter last year. In addition, ANALOGIC CORP has also vastly surpassed the industry average cash flow growth rate of -28.79%.
  • Looking at where the stock is today compared to one year ago, we find that it is not only higher, but it has also clearly outperformed the rise in the S&P 500 over the same period, despite the company's weak earnings results. Turning our attention to the future direction of the stock, it goes without saying that even the best stocks can fall in an overall down market. However, in any other environment, this stock still has good upside potential despite the fact that it has already risen in the past year.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.